Greenspring Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1922200 Towson, MD

Position in JNJ

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,141,729

+$289,363 QoQ

Shares Held

8,433

+11.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.91%

of 13F equity value

Holder Rank

#2,292

of 4,676 holders

Holding Since

Dec 2021

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Greenspring Advisors, LLC holds $12,307,212 across 8 Drug Manufacturers - General names. JNJ ranks #3 (17.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,171	$3,803,392
2	AMGN	Amgen Inc	6,730	$2,437,067
3	JNJ	Johnson & Johnson This page	8,433	$2,141,729
4	ABBV	AbbVie Inc.	6,143	$1,545,824
5	MRK	Merck & Co., Inc.	7,857	$1,009,624
6	NVS	Novartis AG	4,173	$653,992
7	GILD	Gilead Sciences, Inc.	3,135	$396,075
8	AZN	Astrazeneca PLC	1,685	$319,509

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,141,729	8,433	+11.3%	Shares	Sole	2026-08-11
2026-03-31	$1,852,366	7,578	+3.1%	Shares	Sole	2026-05-05
2025-12-31	$1,521,703	7,353	+375.0%	Shares	Sole	2026-02-10
2024-12-31	$223,871	1,548	0.0%	Shares	Sole	2025-01-27
2024-09-30	$250,868	1,548	0.0%	Shares	Sole	2024-10-24
2024-06-30	$226,255	1,548	0.0%	Shares	Sole	2024-07-19
2024-03-31	$244,878	1,548	0.0%	Shares	Sole	2024-04-24
2023-12-31	$242,633	1,548	0.0%	Shares	Sole	2024-01-12
2023-09-30	$241,101	1,548	0.0%	Shares	Sole	2023-10-10
2023-06-30	$256,224	1,548	-72.5%	Shares	Sole	2023-07-20
2023-03-31	$871,565	5,623	+37.1%	Shares	Sole	2023-05-12
2022-12-31	$724,441	4,101	-2.4%	Shares	Sole	2023-02-09
2022-09-30	$686,112	4,200	-2.8%	Shares	Sole	2022-11-02
2022-06-30	$766,843	4,320	-5.3%	Shares	Sole	2022-07-11
2022-03-31	$808,877	4,564	+3.3%	Shares	Sole	2022-05-04
2021-12-31	$755,616	4,417	—	Shares	Sole	2022-04-07
No filing history on record for this holder in this stock.